Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3
Antonio C. Fuentes-Fayos(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Raúl M. Luque(Instituto de Salud Carlos III)
Cited by 103
Related Papers
Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence
|EBioMedicine|2023|45
SF3B1 inhibition disrupts malignancy and prolongs survival in glioblastoma patients through BCL2L1 splicing and mTOR/ß-catenin pathways imbalances
|Journal of Experimental & Clinical Cancer Research|2022|40
Obesity and metabolic dysfunction severely influence prostate cell function: role of insulin and <scp>IGF</scp>1
|Journal of Cellular and Molecular Medicine|2017|23